Observing health issues faced by travelers
Observational Study of Travellers Pathologies
NA · Institut Pasteur · NCT06701890
This study is trying to find out how often travelers get sick when visiting emerging countries and what factors might increase their risk, so we can give better advice to help keep them healthy.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 11000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut Pasteur (industry) |
| Locations | 1 site (Paris) |
| Trial ID | NCT06701890 on ClinicalTrials.gov |
What this trial studies
This study aims to identify the incidence of travel-related illnesses among individuals traveling to emerging countries. It focuses on understanding the behavioral, geographical, and environmental risk factors associated with these health issues, including gastrointestinal and respiratory infections, malaria, and road traffic accidents. The study includes two sub-studies: EOP-Arbo, which investigates the risk of arboviral diseases through blood sample collection, and EOP-AMR, which examines antibiotic-resistant bacteria through fecal sample collection. The findings will help develop targeted recommendations to minimize health risks for travelers.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are preparing to travel outside mainland France and have a smartphone for data collection.
Not a fit: Patients traveling for less than 3 days or more than 12 months, or those unable to provide consent, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved health recommendations for travelers, reducing the incidence of travel-related illnesses.
How similar studies have performed: Other studies have shown success in identifying travel-related health risks, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
1. Inclusion Criteria :
1. For all participants in the EOP study :
* Major subject (age ≥ 18)
* Owns a smartphone compatible with electronic data collection
* Preparing to travel outside mainland France
* Affiliated with or covered by Social Security or private insurance
* Willing to participate in the EOP study
2. For the EOP-Arbo Sub-study :
\- Subject who has consented to participate in the EOP\_Arbo study.
3. For the EOP-AMR Sub-study :
* Subject who has consented to participate in the EOP\_AMR study.
2. Exclusion Criteria:
1. For all participants in the EOP study :
* Travel duration ≤ 3 days
* Travel duration \> 12 months
* Person traveling as part of an expatriation without planned movement outside the settlement in the destination country
* Person under legal protection or unable to express consent for participation
2. For the EOP-Arbo Sub-study :
\- Individuals deemed clinically and/or biologically unfit by the investigator to undergo the blood samples required for the study.
3. For the EOP-AMR Sub-study :
* No specific exclusion criteria.
Where this trial is running
Paris
- Medical Center of Institut Pasteur — Paris, France (RECRUITING)
Study contacts
- Principal investigator: Fabien TAIEB, MD — Medical Center of Institut Pasteur
- Study coordinator: Fabien TAIEB, MD
- Email: fabien.taieb@pasteur.fr
- Phone: 0140613456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Travel-Related Illness, Travel, Risk Factors, Pathology, Arbovirose